[go: up one dir, main page]

ES8402570A1 - Procedimiento para la preparacion de nuevos aminoacidos biciclicos. - Google Patents

Procedimiento para la preparacion de nuevos aminoacidos biciclicos.

Info

Publication number
ES8402570A1
ES8402570A1 ES521741A ES521741A ES8402570A1 ES 8402570 A1 ES8402570 A1 ES 8402570A1 ES 521741 A ES521741 A ES 521741A ES 521741 A ES521741 A ES 521741A ES 8402570 A1 ES8402570 A1 ES 8402570A1
Authority
ES
Spain
Prior art keywords
alkyl
preparation
hydrogen
aryl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521741A
Other languages
English (en)
Other versions
ES521741A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES521741A0 publication Critical patent/ES521741A0/es
Publication of ES8402570A1 publication Critical patent/ES8402570A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE AMINOACIDOS BICICLICOS, DE FORMULA GENERAL (I).COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE ACILA UN COMPUESTO DE FORMULA (II), EN EL QUE N TIENE EL SIGNIFICADO YA MENCIONADO, Y A CONTINUACION SE OXIDA ANODICAMENTE CON UN ALCOHOL EN PRESENCIA DE UNA SAL CONDUCTORA, PARA OBTENER UN COMPUESTOS INTERMEDIO; SEGUNDA, DICHO COMPUESTO INTERMEDIO SE HACE REACCIONAR CON CIANURO DE TRIMETILSILILO EN PRESENCIA DE UN ACIDO DE LEWIS, PARA OBTENER UN SEGUNDO COMPUESTO INTERMEDIO; Y POR ULTIMO, DICHO SEGUNDO COMPUESTO INTERMEDIO DEHIDROLIZA POR LA ACCION DE ACIDOS O BASES PARA OBTENER EL COMPUESTO DE FORMULA (I) BUSCADO.
ES521741A 1982-03-30 1983-04-22 Procedimiento para la preparacion de nuevos aminoacidos biciclicos. Expired ES8402570A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823211676 DE3211676A1 (de) 1982-03-30 1982-03-30 Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
ES521741A0 ES521741A0 (es) 1984-02-01
ES8402570A1 true ES8402570A1 (es) 1984-02-01

Family

ID=6159702

Family Applications (2)

Application Number Title Priority Date Filing Date
ES521041A Granted ES521041A0 (es) 1982-03-30 1983-03-28 Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
ES521741A Expired ES8402570A1 (es) 1982-03-30 1983-04-22 Procedimiento para la preparacion de nuevos aminoacidos biciclicos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES521041A Granted ES521041A0 (es) 1982-03-30 1983-03-28 Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.

Country Status (17)

Country Link
EP (1) EP0090362A3 (es)
JP (1) JPS58177967A (es)
KR (1) KR840004069A (es)
AU (1) AU560124B2 (es)
CA (1) CA1198118A (es)
DE (1) DE3211676A1 (es)
DK (1) DK144783A (es)
ES (2) ES521041A0 (es)
FI (1) FI831049L (es)
GR (1) GR78157B (es)
HU (1) HU193876B (es)
IL (1) IL68267A (es)
NO (2) NO831168L (es)
NZ (1) NZ203719A (es)
PH (1) PH19003A (es)
PT (1) PT76472B (es)
ZA (1) ZA832229B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
CA1341296C (en) * 1981-12-29 2001-09-25 Hansjorg Urbach 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
DE3246503A1 (de) * 1982-12-16 1984-06-20 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
US5175306A (en) * 1983-01-31 1992-12-29 Hoechst Aktiengesellschaft Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters
DE3303344A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern
FI841052A7 (fi) * 1983-03-16 1984-09-17 Usv Pharma Corp Foereningar foer behandling av blodtryckssjukdomar.
FR2546886B2 (fr) * 1983-06-06 1986-05-16 Adir Derives d'acides isoindoledicarboxyliques, leur preparation et compositions pharmaceutiques les contenant
DE3333454A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
DE3333455A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung n-alkylierter dipeptide und deren estern
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
US5684016A (en) * 1984-04-12 1997-11-04 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
JPS61502818A (ja) * 1984-07-30 1986-12-04 シェリング・コ−ポレ−ション シス、エンド−オクタヒドロシクロペンタ〔ｂ〕ピロ−ル−２−カルボキシレ−トの新規製造方法
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
US5231080A (en) * 1985-10-15 1993-07-27 Hoechst Aktiengesellschaft Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
DE3639879A1 (de) * 1986-11-21 1988-06-01 Hoechst Ag Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung
DE3722007A1 (de) * 1987-07-03 1989-01-12 Hoechst Ag Verfahren zur herstellung bicyclischer aminocarbonsaeuren, zwischenprodukte dieses verfahrens und deren verwendung
JPH0278659A (ja) * 1988-09-12 1990-03-19 Shionogi & Co Ltd アザビシクロアルカン類化合物
DE3839127A1 (de) * 1988-11-19 1990-05-23 Hoechst Ag Pyrrolidon-2-carbonsaeure-derivate mit psychotroper wirkung
DD284030A5 (de) 1988-11-24 1990-10-31 Hoechst Ag,De Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
ES2171768T3 (es) 1996-03-20 2002-09-16 Hoechst Ag Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina.
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
EP0932617B1 (en) 1996-10-18 2002-01-16 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
MY148123A (en) 2003-09-05 2013-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
DE602006013492D1 (de) * 2005-08-19 2010-05-20 Vertex Pharma Verfahren und zwischenprodukte
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
US8039475B2 (en) 2006-02-27 2011-10-18 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
NZ571280A (en) 2006-03-16 2011-10-28 Vertex Pharma Deuterated hepatitis C protease inhibitors
AR065498A1 (es) 2007-02-27 2009-06-10 Vertex Pharma Co- critales de vx-950 (un inhibidor del virus de la hepatitis c) y composiciones farmaceuticas que los comprenden
AU2008219704A1 (en) 2007-02-27 2008-09-04 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AU2008297015B2 (en) 2007-08-30 2013-08-22 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
CN102816106A (zh) 2008-06-24 2012-12-12 默沙东公司 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法
JP5829529B2 (ja) * 2011-08-29 2015-12-09 日本曹達株式会社 光学活性４級アンモニウム塩、および光学活性化合物の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
LU88621I2 (fr) * 1980-10-23 1995-09-01 Schering Corp Sandopril
DE3276311D1 (en) * 1981-02-17 1987-06-19 Warner Lambert Co Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
ZA826022B (en) * 1981-08-21 1983-08-31 Univ Miami Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
EP0081094A1 (en) * 1981-11-12 1983-06-15 Merck & Co. Inc. Substituted omega-amino-carboxymethyldipeptide antihypertensive agents
EP0088350B1 (en) * 1982-03-08 1985-02-20 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU193876B (en) 1987-12-28
ES8401937A1 (es) 1984-01-01
EP0090362A3 (de) 1985-09-18
CA1198118A (en) 1985-12-17
IL68267A0 (en) 1983-06-15
ES521741A0 (es) 1984-02-01
AU560124B2 (en) 1987-04-02
AU1297083A (en) 1983-10-06
NZ203719A (en) 1986-02-21
FI831049A7 (fi) 1983-10-01
FI831049A0 (fi) 1983-03-28
GR78157B (es) 1984-09-26
NO831168L (no) 1983-10-03
DE3211676A1 (de) 1983-10-06
PT76472A (de) 1983-04-01
PH19003A (en) 1985-12-03
DK144783D0 (da) 1983-03-29
ZA832229B (en) 1983-12-28
IL68267A (en) 1987-03-31
EP0090362A2 (de) 1983-10-05
NO834352L (no) 1983-10-03
ES521041A0 (es) 1984-01-01
DK144783A (da) 1983-10-01
JPS58177967A (ja) 1983-10-18
FI831049L (fi) 1983-10-01
KR840004069A (ko) 1984-10-06
PT76472B (de) 1986-01-24

Similar Documents

Publication Publication Date Title
ES8402570A1 (es) Procedimiento para la preparacion de nuevos aminoacidos biciclicos.
ES8607281A1 (es) Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
BG50156A3 (en) Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidine- acetamide
ES535452A0 (es) Procedimiento para preparar derivados del acido 2-azabiciclo (3.1.0) hexan-3-carboxilico
MX171822B (es) Proceso quimico
AR241474A1 (es) Preparacion de derivados de acido 3-aciltriciclo ¡5.2.1.0(2.6)¿-3-azadecan-4-carboxilico utiles como inhibidores de la enzima convertidora en angiotensina.
PT81898B (pt) Processo para a preparacao de tieno-triazolo-1,4-diazepino-2-carboxamidas e de composicoes farmaceuticas contendo estes compostos
ATE28565T1 (de) Spiro(4.(3+n))-2-aza-alkan-3-carbonsaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung.
ES8404352A1 (es) Procedimiento para la preparacion de nuevos derivados de acido 2-aza-biciclo(2.2.2)octan-3-carboxilico
ES530290A0 (es) Procedimiento para preparar derivados de aminoacidos espirociclicos.
ES2001978A6 (es) Un procedimiento nuevo para la preparacion de analogos de 7-amino-mitosano
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
DE3585523D1 (de) Reaktionsprodukte von alkenylsuccinverbindungen mit aromatischen aminen und diese enthaltende schmiermittelzusammensetzungen.
ZA853829B (en) Beta-lactam antibiotics,process for the preparation and their use as medicaments or growth-promoters in livestock rearing or as antioxidants
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
ES8106730A1 (es) Un procedimiento para preparar benzoxazepinas.
ES8203916A1 (es) Procedimiento para preparar n6-adenosina
ES546366A0 (es) Procedimiento para preparar derivados de 1,6-naftiridina
ES8707508A1 (es) Procedimiento para preparar derivados del estilbeno asimetricos conteniendo triazinilo
ES2012519A6 (es) Procedimiento para preparar compuestos polifluorados.
ES8609319A1 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
ES8501401A1 (es) Procedimiento para preparar nuevos derivados del azabiciclo heptano.
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ES2019871B3 (es) 1,2,3,4,4a,9b-hexahidro-4a-aminoalquildibenzofuranos, un proceso para su preparacion y su uso como medicamentos.
ES522418A0 (es) Un procedimiento para preparar -15-desoxiespergualina.